LAUSR

PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment

Sign Up to like & get
recommendations!
1 Published in 2017 at "Leukemia"

DOI: 10.1038/leu.2017.110

Abstract: PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment read more here.

Keywords: plcg2; occur btk; mutations occur; domain mutations ... See more keywords

PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma

Sign Up to like & get
recommendations!
0 Published in 2021 at "Medicine"

DOI: 10.1097/md.0000000000025008

Abstract: Abstract The tumor microenvironment (TME) plays an important role in the occurrence and development of soft tissue sarcoma (STS). A number of studies have shown that to inhibit tumor growth, the TME can be remodeled… read more here.

Keywords: tissue sarcoma; plcg2; tumor microenvironment; tumor ... See more keywords